1.03  0 (0%)		09-15 16:00
Open: 3.395 High: 3.42 Volume: 1,131,676		Pre. Close: 1.03 Low: 0.8425 Market Cap: 1(M)

Short term
Mid term
Targets	6-month :	3.75	1-year :	5.81
Resists	First :	3.21	Second :	4.98
Pivot price	1.89
Supports	First :	0.36	Second :	0.3
MAs	MA(5) :	0.54	MA(20) :	2.44
	MA(100) :	6.71	MA(250) :	25.72
MACD	MACD :	-1.2	Signal :	-1
%K %D	K(14,3) :	3.1	D(3) :	3.6
RSI	RSI(14): 17
52-week	High :	89.4	Low :	0.36

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ FEED ] has closed above bottom band by 25.7%. Bollinger Bands are 81.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	0.65 - 0.65	0.65 - 0.66
Low:	0.4 - 0.4	0.4 - 0.4
Close:	0.4 - 0.4	0.4 - 0.41

NanoVibronix, Inc. focuses on developing non-surgical medical devices that stimulate biological responses. Its core offerings include UroShield and PainShield. The company's business activities span across several global markets, such as the United States, Europe, Australia, India, and Israel, in addition to other territories. This enterprise was founded by Harold Jacob and Jona Zumeris in September 2003, and its main corporate office is situated in Tyler, Texas.

Tue, 06 Oct 2026
Operating cash flow per share of ENvue Medical, Inc – OTC:FEED - TradingView

Thu, 17 Sep 2026
ENvue Medical, Inc Revenue Breakdown – OTC:FEED - TradingView

Wed, 16 Sep 2026
ENvue Medical (OTCPK:FEED) - Stock Analysis - Simply Wall Street

Tue, 15 Sep 2026
ENvue Medical Provides Nasdaq Listing Update - GlobeNewswire

Fri, 04 Sep 2026
ENvue Medical, Inc. SEC Filing (Sep 4, 2026) - Stock Titan

Wed, 02 Sep 2026
ENvue Medical Selected to Exhibit ENvue™ Navigation Platform at Vizient Innovative Technology Exchange - Yahoo Finance

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Specialties
Shares Out	0 (M)
Shares Float	1 (M)
Held by Insiders	923720 (%)
Held by Institutions	16.4 (%)
Shares Short	13 (K)
Shares Short P.Month	0 (K)

EPS	-1.414e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-2 %
Return on Assets (ttm)	290.3 %
Return on Equity (ttm)	-21 %
Qtrly Rev. Growth	1.93e+006 %
Gross Profit (p.s.)	-37.4
Sales Per Share	-42.86
EBITDA (p.s.)	-363768
Qtrly Earnings Growth	-302.7 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-12 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	-0.01
Price to Cash Flow	0.06

Dividend	0
Forward Dividend	28670
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.